| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Antihormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Exogenous hormones (substance) |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| 3-beta-androstanediol (substance) |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peptide hormones and their metabolites and precursors |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Catecholamine and/or catecholamine derivative |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prostaglandin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prepro-opiomelanocortin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Melatonin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hormones and their metabolites and precursors A - G |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hormones and their metabolites and precursors H - S |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hormones and their metabolites and precursors T - Z |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sex hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Non-sex hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fetoplacental hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pituitary or adrenal hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antiestrogen |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Substance with androgen receptor antagonist mechanism of action |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antigonadotropin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antimineralocorticoid |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bicalutamide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing selective estrogen receptor modulator (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing finasteride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing carbimazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbimazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbimazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Propylthiouracil 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Finasteride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clomiphene citrate 50mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cyclofenil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Metyrapone 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gestrinone 2.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely trilostane 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely trilostane 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Raloxifene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Raloxifene hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mifepristone 200mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lynestrenol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gestronol hexanoate 200mg/2mL oily injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyproterone acetate 100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tamoxifen 10mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tamoxifen 20mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tamoxifen 10mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely tamoxifen 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flutamide 250mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing androgen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Combined oral contraceptive product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyproterone acetate+ethinyloestradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phased cocs- ethinylestradiol+levonorgestrel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sex hormone product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing estrogen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| hormones, produits de substitution synthétiques et antagonistes |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Thiourea antithyroid agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Thiouracil antithyroid agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gestronol (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phased oral contraceptive |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fertility agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Toremifene citrate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyproterone acetate preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mineralocorticoids and their antagonists |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antigonadotrophins, antiestrogens, antiandrogens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nafoxidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Médicament progestatif |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hormone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing trilostane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing synthetic hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clomifene-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cortisone derivative |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucocorticoids and synthetic analogs (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing propylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iothiouracil-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| médicament antithyroidien |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing metyrapone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Natural hormone preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral contraceptive preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing clomifene citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylthiouracil-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Androgen receptor agonist-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tamoxifen-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing norgestomet (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing altrenogest (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Synthetic antihormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing synthetic antiandrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cyproterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing flutamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing synthetic antiestrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing toremifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Synthetic antigonadotropin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gestrinone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing paroxypropione (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing mifepristone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Endocrine drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Drugs for hypoglycemia |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diabetic neuropathy treatment [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Corticosteroid replacement therapy |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Steroid disease suppression [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Corticosteroid disadvantages [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]